Literature DB >> 28570769

Incidental positive lymph nodes in patients with papillary thyroid cancer is independently associated with recurrent disease.

Wouter P Kluijfhout1,2, Frederick T Drake1, Jesse D Pasternak3, Toni Beninato1, Menno R Vriens2, Wen T Shen1, Jessica E Gosnell1, Chienying Liu4, Insoo Suh1, Quan-Yang Duh1.   

Abstract

BACKGROUND AND OBJECTIVES: Pathological examination occasionally reveals incidental central lymph nodes metastasis (iLNM) after thyroidectomy for patients with papillary thyroid cancer (PTC) who did not undergo compartment-orientated lymphadenectomy. We aimed to investigate the risk of recurrence for patients with iLNM.
METHODS: We conducted a retrospective review of all patients undergoing total thyroidectomy for PTC (January 2000 to January 2010). Patients with distant metastases, central- or lateral neck dissection and pre-operative suspicious lymph nodes (by ultrasound or clinical examination) were excluded. The association between iLNM and recurrent disease was investigated using Kaplan-Meier survival estimates and Cox proportional hazards analysis.
RESULTS: 225/1000 patients had incidental nodes after total thyroidectomy for PTC. 183 were node-negative and 42 had iLNM. Mean age was 46 years and 201 (89%) were women. Mean number of resected nodes was 2.3. Disease recurred in 8/183 (4.4%) of patients with N0 versus 7/42 (17%) with iLNM. After adjusting for other factors, iLNM was independently associated with recurrent disease (hazard ratio = 4.01 [95% CI 1.21-13.3]).
CONCLUSIONS: Positive incidental lymph nodes are independently associated with recurrent disease in patients with PTC. These patients should therefore be monitored more carefully.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  ATA guidelines; incidental lymph nodes; papillary thyroid cancer; recurrence

Mesh:

Year:  2017        PMID: 28570769     DOI: 10.1002/jso.24680

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Treatment-Free Survival in Patients With Differentiated Thyroid Cancer.

Authors:  Mousumi Banerjee; David Reyes-Gastelum; Megan R Haymart
Journal:  J Clin Endocrinol Metab       Date:  2018-07-01       Impact factor: 5.958

2.  The systemic immune-inflammation index-based model is an effective biomarker on predicting central lymph node metastasis in clinically nodal-negative papillary thyroid carcinoma.

Authors:  Zeyu Zhang; Fada Xia; Wenlong Wang; Yun Huang; Xinying Li
Journal:  Gland Surg       Date:  2021-04

3.  A nomogram to predict skip metastasis in papillary thyroid cancer.

Authors:  Wenlong Wang; Zhi Yang; Qianhui Ouyang
Journal:  World J Surg Oncol       Date:  2020-07-15       Impact factor: 2.754

4.  Lymphatic Vessel Invasion in Routine Pathology Reports of Papillary Thyroid Cancer.

Authors:  Costanza Chiapponi; Hakan Alakus; Matthias Schmidt; Michael Faust; Christiane J Bruns; Reinhard Büttner; Marie-Lisa Eich; Anne M Schultheis
Journal:  Front Med (Lausanne)       Date:  2022-02-21

5.  Extrathyroidal extension and cervical node infiltration are associated with recurrences and shorter recurrence-free survival in differentiated thyroid cancer: a cohort study.

Authors:  Sumadi Lukman Anwar; Roby Cahyono; Suwardjo Suwardjo; Herjuna Hardiyanto
Journal:  Thyroid Res       Date:  2022-07-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.